drug
ramipril
Marketedupdated 3mo agoby CorePharma LLC
Approvedcommunity read0 votes
🐶 often sniffed alongside
top 2indications
investigational
Hypertension
all catalysts(0)
nothing on the calendar yet
Trials studying ramipril
- phase4Open-label inteRventional Clinical Trial to Assess Efficacy and Safety of the exteMporaneous combInation of Nebivolol and Ramipril in hypertenSIve pAtients
- phase3Comparison of Standard Versus Low Dose Advagraf® With or Without Angiotensin-converting Enzyme Inhibitor (ACEi)/Angiotensin Receptor Blocker (ARB) on Histology and Function of Renal Allografts
- phase1Ramipril 10 mg Capsule in Healthy Subjects Under Fed Conditions
- phase1Ramipril 10 mg Capsule in Healthy Subjects Under Fasting Conditions
- phase1Ramipril 10 mg Capsule in Healthy Subjects Under Fasting Conditions
- phase3HYZAAR vs. Ramipril for Diabetes (0954A-245)(COMPLETED)
- phase1Bioequivalence Study of Two Formulations of Tablets Ramipril/Hydrochlorothiazide 10 mg/25 mg in Healthy Volunteers Under Fasting Conditions
- phase4PROBE Investigation of the Safety & Efficacy of Telmisartan (Micardis®) vs Ramipril (Altace®) Using ABPM in HTN
Patent cliff
source: FDA Orange Bookfirst barrier falls
Aug 16, 2039
~13.0 years out
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
patents (1)
- Aug 16, 2039formulationUS 12343338
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 13m ago
Found something off?
comments(0)
5-min edit window · permanent after that